nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—endothelium—periodontitis	0.0662	0.162	CbGeAlD
Dabigatran etexilate—F2—Blood Clotting Cascade—SERPINF2—periodontitis	0.0454	0.0768	CbGpPWpGaD
Dabigatran etexilate—F2—neck—periodontitis	0.0437	0.107	CbGeAlD
Dabigatran etexilate—CES2—trigeminal ganglion—periodontitis	0.042	0.103	CbGeAlD
Dabigatran etexilate—CES1—neck—periodontitis	0.0401	0.098	CbGeAlD
Dabigatran etexilate—CES2—parotid gland—periodontitis	0.0396	0.097	CbGeAlD
Dabigatran etexilate—NQO2—trigeminal ganglion—periodontitis	0.0376	0.0919	CbGeAlD
Dabigatran etexilate—NQO2—parotid gland—periodontitis	0.0354	0.0866	CbGeAlD
Dabigatran etexilate—F2—connective tissue—periodontitis	0.0313	0.0765	CbGeAlD
Dabigatran etexilate—F2—epithelium—periodontitis	0.0297	0.0727	CbGeAlD
Dabigatran etexilate—CES1—connective tissue—periodontitis	0.0287	0.0703	CbGeAlD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—SERPINF2—periodontitis	0.0206	0.0349	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—TIMP1—periodontitis	0.0196	0.0332	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—TLR2—periodontitis	0.0187	0.0316	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL18—periodontitis	0.0144	0.0243	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—MMP1—periodontitis	0.0136	0.0229	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Phase II conjugation—GGT1—periodontitis	0.0126	0.0213	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—MPO—periodontitis	0.0125	0.0212	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—GGT1—periodontitis	0.0113	0.0191	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—MMP2—periodontitis	0.0105	0.0178	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—MPO—periodontitis	0.0102	0.0173	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—CCL2—periodontitis	0.00991	0.0168	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—AGER—periodontitis	0.00898	0.0152	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPAR Alpha Pathway—PPARA—periodontitis	0.00883	0.0149	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IFNG—periodontitis	0.00843	0.0143	CbGpPWpGaD
Dabigatran etexilate—ABCB1—trigeminal ganglion—periodontitis	0.00811	0.0198	CbGeAlD
Dabigatran etexilate—F2—Selenium Micronutrient Network—MPO—periodontitis	0.0081	0.0137	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL3—periodontitis	0.00767	0.013	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL1B—periodontitis	0.00752	0.0127	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—GGT1—periodontitis	0.00736	0.0124	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINF2—periodontitis	0.00717	0.0121	CbGpPWpGaD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—FGF2—periodontitis	0.00712	0.012	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—MMP9—periodontitis	0.00709	0.012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00675	0.0114	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—GGT1—periodontitis	0.00665	0.0113	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CRP—periodontitis	0.00659	0.0112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—epithelium—periodontitis	0.00639	0.0156	CbGeAlD
Dabigatran etexilate—F2—Folate Metabolism—IL4—periodontitis	0.00621	0.0105	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—GGT1—periodontitis	0.00614	0.0104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GGT1—periodontitis	0.00573	0.00969	CbGpPWpGaD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—MMP9—periodontitis	0.00563	0.00953	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CCL2—periodontitis	0.00542	0.00918	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CRP—periodontitis	0.00537	0.00908	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—AGER—periodontitis	0.00529	0.00896	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—periodontitis	0.00524	0.00887	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00514	0.0087	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—FGF2—periodontitis	0.00498	0.00843	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR2—periodontitis	0.00494	0.00836	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GGT1—periodontitis	0.00465	0.00787	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IFNG—periodontitis	0.00461	0.0078	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CCL2—periodontitis	0.00441	0.00747	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CRP—periodontitis	0.00426	0.00721	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—periodontitis	0.00411	0.00696	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—MMP1—periodontitis	0.00392	0.00664	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL3—periodontitis	0.00392	0.00663	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—CD14—periodontitis	0.00391	0.00662	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00388	0.00656	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCR2—periodontitis	0.00384	0.0065	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC52A3—periodontitis	0.00384	0.00649	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GGT1—periodontitis	0.00382	0.00646	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—TGFB1—periodontitis	0.0038	0.00642	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.0038	0.00642	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IFNG—periodontitis	0.00375	0.00635	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINF2—periodontitis	0.0037	0.00625	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CCL2—periodontitis	0.00351	0.00593	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.00339	0.00573	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—GGT1—periodontitis	0.00335	0.00567	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—periodontitis	0.00335	0.00566	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TIMP1—periodontitis	0.00332	0.00562	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00332	0.00561	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00327	0.00553	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GGT1—periodontitis	0.0031	0.00525	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL13—periodontitis	0.00307	0.0052	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—AGER—periodontitis	0.00304	0.00514	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—periodontitis	0.00303	0.00513	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—TNF—periodontitis	0.00299	0.00505	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IFNG—periodontitis	0.00298	0.00504	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS2—periodontitis	0.00286	0.00484	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL17A—periodontitis	0.00283	0.00478	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—PPARA—periodontitis	0.00279	0.00471	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—periodontitis	0.00273	0.00461	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—GGT1—periodontitis	0.00272	0.00461	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—periodontitis	0.00266	0.0045	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00264	0.00446	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.00263	0.00445	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00258	0.00436	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00257	0.00434	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR2—periodontitis	0.00252	0.00427	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—AGER—periodontitis	0.00247	0.00418	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.00246	0.00416	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TNF—periodontitis	0.00243	0.00411	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL6—periodontitis	0.00241	0.00408	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ACP5—periodontitis	0.00226	0.00383	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—TGFB1—periodontitis	0.00224	0.00379	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL3—periodontitis	0.00221	0.00375	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—FGF2—periodontitis	0.00208	0.00352	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL3—periodontitis	0.00201	0.0034	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCR2—periodontitis	0.00196	0.00332	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL6—periodontitis	0.00196	0.00332	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ADRB1—periodontitis	0.00195	0.00331	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1A—periodontitis	0.00193	0.00327	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—TNF—periodontitis	0.00193	0.00326	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL10—periodontitis	0.00192	0.00325	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL2—periodontitis	0.00189	0.0032	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—periodontitis	0.00188	0.00318	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL4—periodontitis	0.00187	0.00316	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC52A3—periodontitis	0.00175	0.00296	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TIMP1—periodontitis	0.00171	0.00289	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	0.0017	0.00288	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—VIP—periodontitis	0.0016	0.00271	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—periodontitis	0.00156	0.00263	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL8—periodontitis	0.0015	0.00253	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—VIP—periodontitis	0.00145	0.00246	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR2—periodontitis	0.00143	0.00241	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC52A3—periodontitis	0.00142	0.0024	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR2—periodontitis	0.0013	0.00219	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—periodontitis	0.00129	0.00217	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00127	0.00215	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GGT1—periodontitis	0.00126	0.00213	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL3—periodontitis	0.00119	0.00201	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IFNG—periodontitis	0.00113	0.00191	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR2—periodontitis	0.00111	0.00188	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB1—periodontitis	0.0011	0.00187	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00108	0.00184	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—MMP1—periodontitis	0.00106	0.0018	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.00105	0.00178	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00105	0.00177	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—periodontitis	0.00104	0.00177	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ACP5—periodontitis	0.00103	0.00174	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—periodontitis	0.00101	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR2—periodontitis	0.00101	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.001	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB1—periodontitis	0.001	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.000989	0.00167	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—periodontitis	0.000967	0.00164	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—periodontitis	0.000959	0.00162	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARA—periodontitis	0.0009	0.00152	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VIP—periodontitis	0.000859	0.00145	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ACP5—periodontitis	0.000837	0.00142	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP1—periodontitis	0.000837	0.00142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.000783	0.00132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR2—periodontitis	0.000765	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—periodontitis	0.000765	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MMP3—periodontitis	0.000764	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000762	0.00129	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000748	0.00127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—periodontitis	0.000731	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—periodontitis	0.000681	0.00115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC52A3—periodontitis	0.000652	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP2—periodontitis	0.000647	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR2—periodontitis	0.000595	0.00101	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000593	0.001	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB1—periodontitis	0.000593	0.001	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—periodontitis	0.000585	0.000991	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GGT1—periodontitis	0.000573	0.00097	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—periodontitis	0.000538	0.00091	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000535	0.000904	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—periodontitis	0.00051	0.000863	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—periodontitis	0.000496	0.00084	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000487	0.000823	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK1—periodontitis	0.000485	0.000821	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT1—periodontitis	0.000466	0.000788	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP3—periodontitis	0.000451	0.000763	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—periodontitis	0.000432	0.000731	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARA—periodontitis	0.00041	0.000694	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—periodontitis	0.000393	0.000664	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000386	0.000654	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACP5—periodontitis	0.000384	0.00065	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000361	0.000611	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARA—periodontitis	0.000333	0.000564	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000326	0.000552	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—periodontitis	0.000293	0.000496	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—periodontitis	0.000267	0.000451	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGF2—periodontitis	0.000265	0.000448	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—periodontitis	0.000232	0.000392	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—periodontitis	0.00022	0.000373	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—periodontitis	0.000217	0.000367	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT1—periodontitis	0.000214	0.000361	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—periodontitis	0.00021	0.000355	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—periodontitis	0.000173	0.000292	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARA—periodontitis	0.000153	0.000259	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—periodontitis	0.00013	0.00022	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—periodontitis	9.94e-05	0.000168	CbGpPWpGaD
